Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
03/2004
03/16/2004US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors
03/16/2004US6706740 Controlling, prevention fungi infections
03/16/2004US6706729 A method for dissociating a metal ion from a zinc finger-containing protein; inhibiting virus
03/16/2004US6706723 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
03/16/2004US6706721 N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
03/16/2004US6706705 Slow and continuous blood pressure reducing action and is useful as an antihypertensive agent
03/16/2004US6706215 Coating compositions stabilized against damage by light, heat and oxygen
03/16/2004US6706021 Anticoagulant for catheters, dialysis machines, syringes, tubes, blood lines and stents; trypsin-like serine proteases such as thrombin; 3-benzylsulfonylamino-6-methyl-1-((2-guanidinooxyethyl) aminocarbonylmethyl)-2-pyridinone
03/11/2004WO2004020441A1 Hetereoaryl nitrile derivatives
03/11/2004WO2004020418A1 2,4- diamino quinazoline and pyridopyrimidine ester derivatives as dihydrofolate reductase inhibitors
03/11/2004WO2004020417A1 2,4-diaminoquinazoline, 2-amino-4-hydroxypteridine and 2,4-diaminopyrimidine ester derivatives as dihydrofolate reductase inhibitors
03/11/2004WO2004020393A1 Dibenzylamine compound and medicinal use thereof
03/11/2004WO2004019868A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives
03/11/2004WO2003091264A3 Non nucleoside reverse transcriptase inhibitors
03/11/2004WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
03/11/2004US20040049039 Treating neurodegenerative, psychotropic, and drug and alcohol induced central and peripheral nervous system disorders.
03/11/2004US20040049036 From diphenyl (4-(4-fluorophenyl)-6-isopropyl-2-(methyl-(methyl sulfonyl)amino)pyrimidin-5-ylmethyl)phosphine and tert-butyl-2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl) acetate; removal of tert-butyl group to form acid or salt
03/11/2004US20040049032 Inhibitors of protein kinases, especially Aurora kinase; anticancer agents
03/11/2004US20040048891 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
03/11/2004US20040048884 3-aminoalkyluracil derivatives, e.g., 1-(2,6-Difluorobenzyl)-5-(3-methoxyphenyl)-6-methyl-3-(N-methyl-N-(2 -pyridylethyl)-aminoethyl)uracil; contraceptives; treating lupus, sex hormone related cancer, benign prostatic hypertrophy, etc.
03/11/2004US20040048880 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
03/11/2004US20040048873 Pyrimidine compounds
03/11/2004US20040048872 Sedatives, anticonvulsants, hypnotics and general anesthetics.
03/11/2004US20040048864 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/11/2004US20040048858 Chalcone derivatives and their use to treat diseases
03/11/2004US20040048853 Compounds, compositions, and methods
03/11/2004US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
03/11/2004US20040048850 Activators of soluble guanylate cyclase.
03/11/2004US20040048797 Regulation of TNF-alpha
03/11/2004US20040047916 Compositions and methods for the treatme of primary and metastatic neoplastic disea using arsenic compounds
03/11/2004DE10238865A1 New carboxamides are melanin-concentrating hormone receptor antagonists, useful for treating e.g. metabolic diseases, diabetes, eating disorders, cardiovascular disease, emotional disorders, reproductive and memory disorders
03/11/2004CA2495914A1 N-biarylmethyl aminocycloalkanecarboxamide derivatives
03/11/2004CA2494931A1 Hetereoaryl nitrile derivatives
03/10/2004EP1396489A1 Heteroaromatic bicyclic derivatives useful as anticancer agents
03/10/2004EP1396488A1 Fused heterocyclic compound and medicinal use thereof
03/10/2004EP1395591A1 Corticotropin releasing factor antagonists
03/10/2004EP1395568A1 4-aminopyrimidine derivatives
03/10/2004EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production
03/10/2004EP1021417B1 Substituted phenyluracils
03/10/2004CN1481379A Substituted pyrrolidines as CCR-3 receptor antagonists
03/10/2004CN1481376A Oxybenzamides derivatives as factor xa inhibitors
03/10/2004CN1481370A Quinazoline derivatives, medicaments contg. said compounds, their utilization and method for prodn. thereof
03/10/2004CN1481369A Substituted phenyluracils compound
03/10/2004CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same
03/09/2004US6703392 Orexin receptor antagonists for obesity or sleeping disorder treatment
03/09/2004US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors
03/04/2004WO2004018476A1 Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
03/04/2004WO2004018473A2 Azapurine derivatives
03/04/2004WO2004018461A2 Antibacterial benzoic acid derivatives
03/04/2004WO2004018436A2 Compounds derived from aryl carbamates, preparation thereof and uses of same
03/04/2004WO2004018435A1 Pyrimidine derivatives as modulators of chemokine receptor activity
03/04/2004WO2004018434A1 Pyrimidine compounds
03/04/2004WO2004018433A1 Pyrimidine derivatives and their use as cb2 modulators
03/04/2004WO2004018410A1 Substituted benzanilide compound and pest control agent
03/04/2004WO2004018058A2 Compounds, compositions, and methods
03/04/2004WO2003088917A3 Regulation of tnf-alpha
03/04/2004WO2002096867A3 Inhibitors of protein kinase for the treatment of disease
03/04/2004US20040044209 Method for producing 4-methyl pyrimidine
03/04/2004US20040044204 Glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents
03/04/2004US20040044199 Cyclic urea compounds and preparation thereof
03/04/2004US20040044075 Alpha acyloxyacetamides for kallikrein and urokinase inhibition
03/04/2004US20040044062 Method of treatment of viral infection including HIV using water soluble fullerenes - III
03/04/2004US20040044047 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/04/2004US20040044013 Antiarthritic agents; side effect reduction
03/04/2004US20040043987 Novel compounds and their use as positive AMPA receptor modulators
03/04/2004US20040043986 Cardiovascular disorders; inflammatory bowel disorders; antiarthritic agents; skin disorders; vision defects; osteoporosis
03/04/2004DE10239042A1 New fused macrocyclic pyrimidine derivatives, useful as e.g. cyclin-dependent kinase inhibitors for treating e.g. cancer, autoimmune, cardiovascular or neurodegenerative diseases or viral infections
03/03/2004EP1394242A2 Cyclic thioureas and their use as additives for lubricating oils
03/03/2004EP1394238A1 Cyclic nitroxyl compounds as additives for lubricating oils
03/03/2004EP1393731A1 Novel use of arylethenesulfonamide derivative
03/03/2004EP1392673A2 1,3-dihydroxybenzene derivatives and colorants containing said compounds
03/03/2004EP1392662A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
03/03/2004EP1392661A1 Diarylurea derivatives useful as anti-inflammatory agents
03/03/2004EP1392660A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
03/03/2004EP1392656A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
03/03/2004EP1392655A2 Potassium channel openers
03/03/2004EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators
03/03/2004EP1392643A2 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
03/03/2004EP1392639A1 Pyruvate derivatives
03/03/2004EP1392311A1 Pyrimidine derivatives as selective inhibitors of cox-2
03/03/2004EP0983290B1 Method for producing polymers having nucleo-bases as side-groups
03/03/2004CN1479727A Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor
03/03/2004CN1479726A 6-(1-fluoroethyl)-t-iodo-4-aminopyrimidine compounds, process for preparing the same and pest controllers for agricultural
03/03/2004CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes
03/03/2004CN1478772A Synthesis method of -N-phenyl-N'-pyridyl substituted carbamide derivative
03/03/2004CN1140515C 3-(2-fluo-4,5,6-substituted phenyl)-1,3-quinazoline-2,4-dione compound with herbiciding activity
03/03/2004CN1140514C Substd, iminoalkoxy-phenyluracils, production and use thereof as herbicides
03/03/2004CN1140513C Phenylsulphenyl ureas, process for their preparation and their use as herbicides and plant-growth regulators
03/03/2004CN1140512C Process for preparation of 4,6-dichloropyrimidine
03/03/2004CN1140269C Bicyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family
03/02/2004US6699994 Biaryl compounds as serine protease inhibitors
03/02/2004US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims
03/02/2004US6699893 Glucocorticoid receptor modulators
03/02/2004US6699891 Npyy5 antagonists
03/02/2004US6699873 Melanocortin-4 receptor binding compounds and methods of use thereof
03/02/2004US6699651 Base precursors for use in a photothermographic element
03/02/2004US6699647 Tellurium chemical sensitizers added to the photothermographic emulsion, for example tellurium complexed with four imidazolidin-2-thione groups and two chlorine atoms
03/02/2004CA2138289C N-substituted azabicycloheptane derivatives, the preparation and use thereof
02/2004
02/26/2004WO2004016598A1 Monomers capable of forming four hydrogen bridges and supramolecular polymers formed by copolymerization of these monomers with regular monomers
02/26/2004WO2004016597A2 Protein kinase inhibitors and uses thereof